An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence.

ABSTRACT:

Aims

To determine whether the provision of contingency management using financial incentives to improve hepatitis B vaccine completion in people who inject drugs entering community treatment represents a cost-effective use of health-care resources.

Design

A probabilistic cost-effectiveness analysis was conducted, using a decision-tree to estimate the short-term clinical and health-care cost impact of the vaccination strategies, followed by a Markov process to evaluate the long-term clinical consequences and costs associated with hepatitis B infection.

Settings and participants

Data on attendance to vaccination from a UK cluster randomized trial.

Intervention

Two contingency management options were examined in the trial: fixed versus escalating schedule financia

SUBMITTER: Rafia R 

PROVIDER: S-EPMC5347913 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature